Login / Signup

Efficacy and safety of three times daily dosing of tacrolimus in pediatric kidney transplantation patients: A single-center comparative study.

Zinah AlabdulkarimAhmed Hamdan Al-JedaiDelal AlkortasKhalid AlhasanEdward Devol
Published in: Pediatric transplantation (2020)
No significant difference was observed between tacrolimus BID and TID dosing in the time to reach therapeutic trough concentration or in the proportion of patients achieving therapeutic trough concentrations at day 7.
Keyphrases
  • end stage renal disease
  • kidney transplantation
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • physical activity
  • patient reported outcomes
  • patient reported